ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 232 filers reported holding ACADIA PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.85 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,437,232 | +645.9% | 212,919 | +757.2% | 0.01% | +500.0% |
| Q2 2023 | $594,894 | +21.6% | 24,839 | -19.1% | 0.00% | -33.3% |
| Q4 2022 | $489,078 | +57.3% | 30,721 | +139.5% | 0.00% | 0.0% |
| Q1 2022 | $311,000 | -87.9% | 12,825 | -73.4% | 0.00% | -91.9% |
| Q4 2020 | $2,578,000 | -67.1% | 48,226 | -70.1% | 0.04% | -67.8% |
| Q2 2020 | $7,825,000 | +2980.7% | 161,431 | +2617.7% | 0.12% | +1337.5% |
| Q4 2019 | $254,000 | – | 5,940 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| March Altus Capital Management LP | 82,723 | $2,685,000 | 20.75% |
| HWG Holdings LP | 289,380 | $9,393,000 | 8.72% |
| Baker Brothers Advisors | 24,516,738 | $795,813,000 | 8.34% |
| HARVEY CAPITAL MANAGEMENT INC | 352,200 | $11,432,000 | 5.73% |
| Belmont Global Advisors, Inc. | 150,000 | $4,869,000 | 4.67% |
| Palo Alto Investors LP | 1,437,730 | $46,669,000 | 3.52% |
| Avoro Capital Advisors LLC | 329,500 | $10,696,000 | 2.38% |
| GARRISON BRADFORD & ASSOCIATES INC | 70,100 | $2,275,000 | 2.23% |
| WEATHERBIE CAPITAL, LLC | 401,642 | $13,037,000 | 1.85% |
| ACUTA CAPITAL PARTNERS, LLC | 85,999 | $2,792,000 | 1.34% |